Trial By Error: Another Letter to NICE’s Sir Andrew Dillon
…leave it as is. The Guidance Executive made the right call, based on the current science, and given the international controversy over PACE trial and other CBT/GET trials. In NICE’s…
…leave it as is. The Guidance Executive made the right call, based on the current science, and given the international controversy over PACE trial and other CBT/GET trials. In NICE’s…
…we do know that Sharpe compared his critics €“ meaning those who reject the PACE trial’s biopsychosocial theory of ME/CFS €“ to climate change deniers, while complaining about what he…
…treat; I think it’s about seven to get a clinically important treatment benefit with CBT and GET. What this trial isn’t able to answer is how much better are these…
…prospective trial registration and biased its findings by swapping outcome measures half-way through. In both cases, the editors have failed to respond adequately and with an appropriate sense of urgency….
…first two debates were held in February and June. In these initial forays, Monaghan focused on the PACE trial, among other issues. In doing so, she provided the single most…
…that I reject that characterization of my work. Regarding the Lightning Process study, I have documented that the trial was not in fact prospectively registered, given that more than half…